首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Application of Tucatinib and Trastuzumab: Dual Anti HER2 Therapy Against HER2 Positive Breast Cancer
Authors:Sumanpreet Kaur  Rajasri Bhattacharyya  Dibyajyoti Banerjee  Jaya Shukla
Institution:1.Department of Experimental Medicine and Biotechnology, PGIMER, Chandigarh, 160012 India ;2.Department of Nuclear Medicine, PGIMER, Chandigarh, 160012 India
Abstract:Synergism in action of tucatinib and trastumab is reported in breast cancer management. However, its molecular basis is yet to be determined. In this context we attempted to provide an explanation at the molecular level by performing in silico experimentation and coupling its result with already available published observations. Our study will provide basis for planning further experimental study for unravelling the truth.
Keywords:Tucatinib  Trastumab  Synergism  Breast cancer
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号